Jefferies Group’s Collegium Pharmaceutical COLL Stock Holding History

Jefferies Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$340K	Buy	+21,250	New	+$375K	﹤0.01%	1182
2022 Q1	–	Sell	-160,885	Closed	-$3.01M	–	1588
2021 Q4	$3.01M	Buy	+160,885	New	+$3.14M	0.02%	640
2021 Q2	–	Sell	-6,500	Closed	-$154K	–	1720
2021 Q1	$154K	Buy	6,500 +3,927	+153%	+$93.3K	﹤0.01%	1401
2020 Q4	$51.5K	Buy	+2,573	New	+$50.2K	﹤0.01%	1493
2018 Q4	–	Sell	-18,405	Closed	-$271K	–	2206
2018 Q3	$271K	Buy	+18,405	New	+$326K	﹤0.01%	1925
2018 Q2	–	Sell	-9,100	Closed	-$233K	–	2350
2018 Q1	$233K	Sell	9,100 -39,300	-81%	-$936K	﹤0.01%	1903
2017 Q4	$893K	Buy	+48,400	New	+$693K	﹤0.01%	1429
2017 Q2	–	Sell	-15,000	Closed	-$151K	–	2227
2017 Q1	$151K	Sell	15,000 -60,811	-80%	-$904K	﹤0.01%	2086
2016 Q4	$1.18M	Buy	+75,811	New	+$1.26M	0.01%	1179

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's COLL Position: Q3 2022 in Review

Jefferies Group opened a new position in Collegium Pharmaceutical (COLL) in Q3 2022: 21,250 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings. This is a return to the name: Jefferies Group previously reported a position in COLL as recently as Q4 2021.

Jefferies Group first reported a position in COLL in Q4 2016 and has held it in 9 quarters since. The position peaked at $3.01M in Q4 2021. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

Jefferies Group held 21,250 shares of Collegium Pharmaceutical worth $340K as of Q3 2022.
Collegium Pharmaceutical was a new Jefferies Group position in Q3 2022.
Collegium Pharmaceutical made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1182 holding.
Jefferies Group first reported a position in Collegium Pharmaceutical in Q4 2016 and has held it in 9 quarters since.
Jefferies Group's Collegium Pharmaceutical position peaked at $3.01M in Q4 2021.
168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.